论文信息 - Vancomycin-induced linear IgA bullous dermatosis

Vancomycin-induced linear IgA bullous dermatosis

Abstract Adverse medication side effects are not uncommon in the inpatient setting, where polypharmacy is the norm. Linear IgA bullous dermatosis (LABD) can be a cutaneous side effect of commonly used inpatient medications, such as vancomycin. Symptoms of LABD can be severe, and proper recognition of this drug-induced disease is important to ensuring proper treatment, including the removal of the inciting agent. This report describes a case of vancomycin-associated LABD in a 66-year-old man and the proper management of drug-induced LABD.

S. Chon | C. Wiggins

[1] T. Volz,et al. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature. , 2019, Acta dermato-venereologica.

[2] P. Wolkenstein,et al. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults , 2017, The British journal of dermatology.

[3] M. Peters-Lawrence,et al. Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia , 2014, American journal of hematology.

[4] J. Roujeau,et al. Linear IgA bullous dermatosis: comparison between the drug‐induced and spontaneous forms , 2013, The British journal of dermatology.

[5] C. Jaworsky,et al. Linear IgA Bullous Disease Presenting as Toxic Epidermal Necrolysis: A Case Report and Review of the Literature , 2013, Dermatology.

[6] J. Callen,et al. Vancomycin‐induced linear IgA bullous disease presenting as toxic epidermal necrolysis , 2004, Clinical and experimental dermatology.

[7] Amin Fazeli,et al. Vancomycin‐induced linear IgA disease manifesting as bullous erythema multiforme , 2004, Journal of cutaneous pathology.

[8] P. H. Mckee,et al. Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses , 1990, Journal of cutaneous pathology.